Sanofi-Aventis U.S. LLC v. Cadila Healthcare Limited
1:16-cv-01298
Overview
Parties
Defendant
Zydus Pharmaceuticals (USA) Inc. Operating Company
Represented By
3 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
MSN Laboratories Private Limited NPE (University / Research)
Represented By
3 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Alvogen Pine Brook LLC Operating Company
Represented By
5 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Amneal Pharmaceuticals LLC Operating Company
Represented By
3 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Glenmark Pharmaceuticals SA NPE (Individual / Inventor)
Represented By
2 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Amneal Pharmaceuticals Co. India Private Limited NPE (University / Research)
Represented By
3 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Biocon Limited NPE (University / Research)
Represented By
4 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Glenmark Pharmaceuticals Inc., USA Operating Company
Represented By
5 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Breckenridge Pharmaceutical, Inc. Operating Company
Represented By
2 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Mylan Pharmaceuticals Inc. Operating Company
Represented By
11 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
MSN Pharmaceuticals Inc. Operating Company
Represented By
1 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Mylan Inc. Operating Company
Represented By
10 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Cadila Healthcare Limited NPE (University / Research)
Represented By
2 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Sanofi Operating Company
Represented By
7 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
RatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Sanofi-Aventis U.S. LLC Operating Company
Represented By
7 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
RatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
8 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Watson Laboratories, Inc. Operating Company
Represented By
8 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Plaintiff
Aventisub LLC Operating Company
Represented By
7 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
RatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Genzyme Corporation NPE (Individual / Inventor)
Represented By
7 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
RatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → |
Sanofi-Aventis U.S. LLC v. Emcure Pharmaceuticals Ltd.
Sanofi-Aventis U.S. LLC v. Par Pharmaceutical, Inc.
Sanofi-Aventis U.S. LLC v. Amneal Pharmaceuticals LLC
Sanofi-Aventis U.S. LLC v. Zydus Pharmaceuticals (USA) Inc.
Sanofi-Aventis U.S. LLC v. Hetero USA Inc.
Sanofi-Aventis U.S. LLC v. Mylan Pharmaceuticals Inc.
Sanofi-Aventis U.S. LLC v. MSN Laboratories Private Limited
Sanofi-Aventis U.S. LLC v. Breckenridge Pharmaceutical, Inc.
Sanofi-Aventis U.S. LLC v. Teva Pharmaceuticals USA, Inc.
Sanofi-Aventis U.S. LLC v. Biocon Limited
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6794410
Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis
|
Filed: 2002-04-01
Issued: 2004-09-21
|
Expired (Term Ended)
+1639d PTA
Expires: 2026-09-26
|
|
|
US9186346
Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
|
Filed: 2014-02-04
Issued: 2015-11-17
|
Active (7.2 yrs remaining)
Expires: 2034-02-04
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+1639 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
33
Dispositive
12
Granted
0
Denied
0
Pending / Review
23
Motions by Category
Key Dispositive Motions & Rulings